The non competitive antagonist of N-methyl-D-aspartate (NMDA) receptors MK-801, at doses which did not produce any behavioural modification per se, increased by about 40% the contralateral turning induced by the dopaminergic (DA) D-1/D-2 agonist L-DOPA in rats bearing a unilateral lesion of the DA nigro striatal neurons. Administration of MK-801 in combination with selective agonists of the D-1 (SKF 38393) or D-2 (LY 171555) receptor, induced an increase of about 280% of D-1 mediated turning and a 70% decrease of D-2 mediated turning. Analysis of the potentiation of L-DOPA mediated turning by MK-801 after selective D-1 receptor blockade by SCH 23390, revealed that the increase of turning was related to the stimulation of D-1 receptors by L-...
We compared the neuroprotective and metabolic effects of chronic treatment with ionotropic or metabo...
In order to study the possible contribution of the substantia nigra (SN) in the positive interaction...
Jing Gan,1 Chen Qi,1 Li-Min Mao,2 Zhenguo Liu11Department of Neurology, Xinhua Hospital, Shanghai Ji...
The non competitive antagonist of N-methyl-D-aspartate (NMDA) receptors MK-801, at doses which did n...
In rats with unilateral lesion of the nigrostriatal dopaminergic pathway, L-DOPA induces contralater...
In rats with unilateral 6-hydroxydopamine (6-OHDA) lesions of the nigrostriatal dopaminergic pathway...
In rats with a unilateral 6-hydroxydopamine lesion of the dopaminergic nigro-striatal pathway, stria...
Dopamine (DA) and glutamate N-methyl-d-aspartate (NMDA) receptors extensively interact in the mediat...
The D1 agonist, SKF 38393, failed to induce contralateral turning in drug-naive rats lesioned unilat...
In rats unilaterally lesioned with 6-hydroxydopamine, the D-1 agonist SKF 38393 (3 mg/kg SC) induced...
The D-1 agonist SKF 38393 (2 mg/kg s.c.) failed to induce contralateral turning in drug-naive rats, ...
In rats with a unilateral lesion of the dopaminergic nigrostriatal pathway with 6-hydroxydopamine, b...
The effects of MK-801, a non-competitive N-methyl D-aspartate (NMDA) receptor antagonist, of quinpir...
In rats lesioned with 6-hydroxydopamine (6-OHDA) the effect of the noncompetitive N-methyl D-asparta...
Parkinson?s Disease (PD) is a neurodegenerative disorder caused by the progressive loss of dopaminer...
We compared the neuroprotective and metabolic effects of chronic treatment with ionotropic or metabo...
In order to study the possible contribution of the substantia nigra (SN) in the positive interaction...
Jing Gan,1 Chen Qi,1 Li-Min Mao,2 Zhenguo Liu11Department of Neurology, Xinhua Hospital, Shanghai Ji...
The non competitive antagonist of N-methyl-D-aspartate (NMDA) receptors MK-801, at doses which did n...
In rats with unilateral lesion of the nigrostriatal dopaminergic pathway, L-DOPA induces contralater...
In rats with unilateral 6-hydroxydopamine (6-OHDA) lesions of the nigrostriatal dopaminergic pathway...
In rats with a unilateral 6-hydroxydopamine lesion of the dopaminergic nigro-striatal pathway, stria...
Dopamine (DA) and glutamate N-methyl-d-aspartate (NMDA) receptors extensively interact in the mediat...
The D1 agonist, SKF 38393, failed to induce contralateral turning in drug-naive rats lesioned unilat...
In rats unilaterally lesioned with 6-hydroxydopamine, the D-1 agonist SKF 38393 (3 mg/kg SC) induced...
The D-1 agonist SKF 38393 (2 mg/kg s.c.) failed to induce contralateral turning in drug-naive rats, ...
In rats with a unilateral lesion of the dopaminergic nigrostriatal pathway with 6-hydroxydopamine, b...
The effects of MK-801, a non-competitive N-methyl D-aspartate (NMDA) receptor antagonist, of quinpir...
In rats lesioned with 6-hydroxydopamine (6-OHDA) the effect of the noncompetitive N-methyl D-asparta...
Parkinson?s Disease (PD) is a neurodegenerative disorder caused by the progressive loss of dopaminer...
We compared the neuroprotective and metabolic effects of chronic treatment with ionotropic or metabo...
In order to study the possible contribution of the substantia nigra (SN) in the positive interaction...
Jing Gan,1 Chen Qi,1 Li-Min Mao,2 Zhenguo Liu11Department of Neurology, Xinhua Hospital, Shanghai Ji...